measurable changes in platelets that are associated with the clinical complications of atherosclerosis include shortened survival , release of granule contents ( platelet factor 4 , beta-thromboglobulin , thrombospondin ) , formation of thromboxanes , and decreased buoyant density .
C0005821
platelets
C0076560
thrombospondin